Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Daclatasvir market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Daclatasvirmarket, defines the market attractiveness level of Daclatasvir market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Daclatasvir industry, describes the types of Daclatasvir market, the applications of major players and the market size, and deeply analyzes the current situation of the global Daclatasvir market and the development prospects and opportunities of Daclatasvir industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Daclatasvir market in Chapter 13.
By Player:
Natco Pharma
Zydus Cadila
Emcure Pharmaceuticals
Abbott
Torrent Pharmaceuticals
Hetero Drugs
Cipla
Mylan
Bristol-Myers Squibb
Dr Reddy's Laboratories
Biocon
By Type:
30mg Tablets
60mg Tablets
By End-User:
Hepatitis C Virus (HCV) Genotype 1
Hepatitis C Virus (HCV) Genotype 3
Hepatitis C Virus (HCV) Genotype 4
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Daclatasvir Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Daclatasvir Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Daclatasvir Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Daclatasvir Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Daclatasvir Market Analysis and Outlook to 2022
-
7.1 Global Daclatasvir Consumption (2017-2022)
-
7.2 United States Daclatasvir Consumption (2017-2022)
-
7.3 Europe Daclatasvir Consumption (2017-2022)
-
7.4 China Daclatasvir Consumption (2017-2022)
-
7.5 Japan Daclatasvir Consumption (2017-2022)
-
7.6 India Daclatasvir Consumption (2017-2022)
-
7.7 South Korea Daclatasvir Consumption (2017-2022)
8 Region and Country-wise Daclatasvir Market Analysis and Outlook to 2028
-
8.1 Global Daclatasvir Consumption Forecast (2022-2028)
-
8.2 United States Daclatasvir Consumption Forecast (2022-2028)
-
8.3 Europe Daclatasvir Consumption Forecast (2022-2028)
-
8.4 China Daclatasvir Consumption Forecast (2022-2028)
-
8.5 Japan Daclatasvir Consumption Forecast (2022-2028)
-
8.6 India Daclatasvir Consumption Forecast (2022-2028)
-
8.7 South Korea Daclatasvir Consumption Forecast (2022-2028)
9 Global Daclatasvir Market Outlook by Types and Applications to 2022
-
9.1 Global Daclatasvir Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 30mg Tablets Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 60mg Tablets Consumption and Growth Rate (2017-2022)
-
9.2 Global Daclatasvir Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hepatitis C Virus (HCV) Genotype 1 Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hepatitis C Virus (HCV) Genotype 3 Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Hepatitis C Virus (HCV) Genotype 4 Consumption and Growth Rate (2017-2022)
10 Global Daclatasvir Market Outlook by Types and Applications to 2028
-
10.1 Global Daclatasvir Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 30mg Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 60mg Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Daclatasvir Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hepatitis C Virus (HCV) Genotype 1 Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hepatitis C Virus (HCV) Genotype 3 Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Hepatitis C Virus (HCV) Genotype 4 Consumption Forecast and Growth Rate (2022-2028)
11 Global Daclatasvir Import and Export Analysis (Top 5 Countries)
-
11.1 Global Daclatasvir Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Daclatasvir Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Daclatasvir Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Daclatasvir Market Competitive Analysis
-
14.1 Natco Pharma
-
14.1.1 Natco Pharma Company Details
-
14.1.2 Natco Pharma Daclatasvir Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Natco Pharma Daclatasvir Product and Service
-
14.2 Zydus Cadila
-
14.2.1 Zydus Cadila Company Details
-
14.2.2 Zydus Cadila Daclatasvir Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Zydus Cadila Daclatasvir Product and Service
-
14.3 Emcure Pharmaceuticals
-
14.3.1 Emcure Pharmaceuticals Company Details
-
14.3.2 Emcure Pharmaceuticals Daclatasvir Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Emcure Pharmaceuticals Daclatasvir Product and Service
-
14.4 Abbott
-
14.4.1 Abbott Company Details
-
14.4.2 Abbott Daclatasvir Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Abbott Daclatasvir Product and Service
-
14.5 Torrent Pharmaceuticals
-
14.5.1 Torrent Pharmaceuticals Company Details
-
14.5.2 Torrent Pharmaceuticals Daclatasvir Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Torrent Pharmaceuticals Daclatasvir Product and Service
-
14.6 Hetero Drugs
-
14.6.1 Hetero Drugs Company Details
-
14.6.2 Hetero Drugs Daclatasvir Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Hetero Drugs Daclatasvir Product and Service
-
14.7 Cipla
-
14.7.1 Cipla Company Details
-
14.7.2 Cipla Daclatasvir Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Cipla Daclatasvir Product and Service
-
14.8 Mylan
-
14.8.1 Mylan Company Details
-
14.8.2 Mylan Daclatasvir Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Mylan Daclatasvir Product and Service
-
14.9 Bristol-Myers Squibb
-
14.9.1 Bristol-Myers Squibb Company Details
-
14.9.2 Bristol-Myers Squibb Daclatasvir Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Bristol-Myers Squibb Daclatasvir Product and Service
-
14.10 Dr Reddy's Laboratories
-
14.10.1 Dr Reddy's Laboratories Company Details
-
14.10.2 Dr Reddy's Laboratories Daclatasvir Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Dr Reddy's Laboratories Daclatasvir Product and Service
-
14.11 Biocon
-
14.11.1 Biocon Company Details
-
14.11.2 Biocon Daclatasvir Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Biocon Daclatasvir Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Daclatasvir
-
Figure Daclatasvir Picture
-
Table Global Daclatasvir Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Daclatasvir Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Daclatasvir Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Daclatasvir Consumption by Country (2017-2022)
-
Figure United States Daclatasvir Consumption and Growth Rate (2017-2022)
-
Table Europe Daclatasvir Consumption and Growth Rate (2017-2022)
-
Figure China Daclatasvir Consumption and Growth Rate (2017-2022)
-
Figure Japan Daclatasvir Consumption and Growth Rate (2017-2022)
-
Figure India Daclatasvir Consumption and Growth Rate (2017-2022)
-
Figure South Korea Daclatasvir Consumption and Growth Rate (2017-2022)
-
Figure Global Daclatasvir Consumption Forecast by Country (2022-2028)
-
Figure United States Daclatasvir Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Daclatasvir Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Daclatasvir Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Daclatasvir Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Daclatasvir Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Daclatasvir Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 30mg Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global 60mg Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis C Virus (HCV) Genotype 1 Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis C Virus (HCV) Genotype 3 Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis C Virus (HCV) Genotype 4 Consumption and Growth Rate (2017-2022)
-
Figure Global 30mg Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 60mg Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatitis C Virus (HCV) Genotype 1 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatitis C Virus (HCV) Genotype 3 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatitis C Virus (HCV) Genotype 4 Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Daclatasvir Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Daclatasvir Export by Region (Top 5 Countries) (2017-2028)
-
Table Natco Pharma (Foundation Year, Company Profile and etc.)
-
Table Natco Pharma Daclatasvir Sales, Price, Value and Gross Profit (2017-2022)
-
Table Natco Pharma Daclatasvir Product and Service
-
Table Zydus Cadila (Foundation Year, Company Profile and etc.)
-
Table Zydus Cadila Daclatasvir Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zydus Cadila Daclatasvir Product and Service
-
Table Emcure Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Emcure Pharmaceuticals Daclatasvir Sales, Price, Value and Gross Profit (2017-2022)
-
Table Emcure Pharmaceuticals Daclatasvir Product and Service
-
Table Abbott (Foundation Year, Company Profile and etc.)
-
Table Abbott Daclatasvir Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Daclatasvir Product and Service
-
Table Torrent Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Torrent Pharmaceuticals Daclatasvir Sales, Price, Value and Gross Profit (2017-2022)
-
Table Torrent Pharmaceuticals Daclatasvir Product and Service
-
Table Hetero Drugs (Foundation Year, Company Profile and etc.)
-
Table Hetero Drugs Daclatasvir Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hetero Drugs Daclatasvir Product and Service
-
Table Cipla (Foundation Year, Company Profile and etc.)
-
Table Cipla Daclatasvir Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla Daclatasvir Product and Service
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Daclatasvir Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Daclatasvir Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Daclatasvir Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Daclatasvir Product and Service
-
Table Dr Reddy's Laboratories (Foundation Year, Company Profile and etc.)
-
Table Dr Reddy's Laboratories Daclatasvir Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dr Reddy's Laboratories Daclatasvir Product and Service
-
Table Biocon (Foundation Year, Company Profile and etc.)
-
Table Biocon Daclatasvir Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Daclatasvir Product and Service
-
